ECCMID 2023: Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatment Additional Data to be Presented Showing Significantly Faster Time to Negative Viral Titer (Culture) Compared to Placebo